about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor t...
Read More
123.82
4.52
(3.79%)
17.6M
XNYS Volume
XNYS 27 Feb, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Merck & Company is on 03 Mar 2026 for the purpose of TD Cowen 46th Annual Health Care Conference
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..